Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  1,506 results for ""Xenograft Model Antitumor Assays""

Your Filters

Subject : neoplastic stem cells
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Combinations of HDAC Inhibitor and PPAR Agonist Induce Ferroptosis of Leukemic Stem Cell-like Cells in Acute Myeloid Leukemia.

  • Authors : Zhou H; Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen, China.; Key Laboratory of Xiamen for Diagnosis and Treatment of Hematological Malignancy, Xiamen, China.

Subjects: Ferroptosis*/Ferroptosis*/Ferroptosis*/drug effects ; Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/drug therapy ; Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/pathology

  • Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Dec 02; Vol. 30 (23), pp. 5430-5444.Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model:

Record details

Read More Add to Saved list
×
Academic Journal

K Ca channel targeting impairs DNA repair and invasiveness of patient-derived glioblastoma stem cells in culture and orthotopic mouse xenografts which only in part is predictable by K Ca expression levels.

  • Authors : Ganser K; Department of Radiation Oncology, University Hospital of Tübingen, Tübingen, Germany.; Stransky N

Subjects: Glioblastoma*/Glioblastoma*/Glioblastoma*/pathology ; Glioblastoma*/Glioblastoma*/Glioblastoma*/metabolism ; Glioblastoma*/Glioblastoma*/Glioblastoma*/genetics

  • Source: International journal of cancer [Int J Cancer] 2024 Nov 15; Vol. 155 (10), pp. 1886-1901. Date of Electronic Publication: 2024 Jun 27.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Combination of monensin and erlotinib synergistically inhibited the growth and cancer stem cell properties of triple-negative breast cancer by simultaneously inhibiting EGFR and PI3K signaling pathways.

  • Authors : Fang T; Engineering Center of Innovativennovative Veterinary Drugs, Center for Veterinary Drug Research and Evaluation, Nanjing Agricultural University, 1 Weigang, Nanjing, 210095, China.; MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, 1 Weigang, Nanjing, 210095, China.

Subjects: Erlotinib Hydrochloride*/Erlotinib Hydrochloride*/Erlotinib Hydrochloride*/pharmacology ; Erlotinib Hydrochloride*/Erlotinib Hydrochloride*/Erlotinib Hydrochloride*/administration & dosage ; Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/drug therapy

  • Source: Breast cancer research and treatment [Breast Cancer Res Treat] 2024 Sep; Vol. 207 (2), pp. 435-451. Date of Electronic Publication: 2024 Jul 03.Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

Effect of PAWI-2 on pancreatic cancer stem cell tumors.

  • Authors : Cashman JR; Human BioMolecular Research Institute, San Diego, 5310 Eastgate Mall, San Diego, CA, 92121, USA. .; Cashman EA

Subjects: Pancreatic Neoplasms*/Pancreatic Neoplasms*/Pancreatic Neoplasms*/drug therapy ; Pancreatic Neoplasms*/Pancreatic Neoplasms*/Pancreatic Neoplasms*/pathology ; Neoplastic Stem Cells*/Neoplastic Stem Cells*/Neoplastic Stem Cells*/drug effects

  • Source: Investigational new drugs [Invest New Drugs] 2024 Aug; Vol. 42 (4), pp. 353-360. Date of Electronic Publication: 2024 May 25.Publisher: Springer Country of Publication: United States NLM ID: 8309330 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

PBI-05204, a supercritical CO 2 extract of Nerium oleander, suppresses glioblastoma stem cells by inhibiting GRP78 and inducing programmed necroptotic cell death.

  • Authors : Chakraborty S; Department of Palliative, Rehabilitation and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Wei D

Subjects: Endoplasmic Reticulum Chaperone BiP* ; Glioblastoma*/Glioblastoma*/Glioblastoma*/pathology ; Glioblastoma*/Glioblastoma*/Glioblastoma*/drug therapy

  • Source: Neoplasia (New York, N.Y.) [Neoplasia] 2024 Aug; Vol. 54, pp. 101008. Date of Electronic Publication: 2024 May 31.Publisher: Elsevier Country of Publication: United States NLM ID: 100886622 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Regorafenib synergizes with TAS102 against multiple gastrointestinal cancers and overcomes cancer stemness, trifluridine-induced angiogenesis, ERK1/2 and STAT3 signaling regardless of KRAS or BRAF mutational status.

  • Authors : Zhang J; Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.; Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Warren Alpert Medical School, Brown University, RI 02912, USA.

Subjects: Trifluridine*/Trifluridine*/Trifluridine*/pharmacology ; Phenylurea Compounds*/Phenylurea Compounds*/Phenylurea Compounds*/pharmacology ; Pyridines*/Pyridines*/Pyridines*/pharmacology

  • Source: Oncotarget [Oncotarget] 2024 Jul 02; Vol. 15, pp. 424-438. Date of Electronic Publication: 2024 Jul 02.Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

Suberanilohydroxamic acid (SAHA), a HDAC inhibitor, suppresses the effect of Treg cells by targeting the c-Myc/CCL1 pathway in glioma stem cells and improves PD-L1 blockade therapy.

  • Authors : Sun T; The Department of Neurosurgery and Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu Province, China.; Liu B

Subjects: T-Lymphocytes, Regulatory*/T-Lymphocytes, Regulatory*/T-Lymphocytes, Regulatory*/drug effects ; T-Lymphocytes, Regulatory*/T-Lymphocytes, Regulatory*/T-Lymphocytes, Regulatory*/immunology ; Histone Deacetylase Inhibitors*/Histone Deacetylase Inhibitors*/Histone Deacetylase Inhibitors*/pharmacology

  • Source: Journal of neuro-oncology [J Neurooncol] 2024 Jul; Vol. 168 (3), pp. 457-471. Date of Electronic Publication: 2024 Apr 23.Publisher: Springer Country of Publication: United States NLM ID: 8309335 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Ursolic acid inhibits the proliferation of triple‑negative breast cancer stem‑like cells through NRF2‑mediated ferroptosis.

  • Authors : Yang X; Graduate School, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, P.R. China.; Liang B

Subjects: Ferroptosis*/Ferroptosis*/Ferroptosis*/drug effects ; Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/drug therapy ; Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/pathology

  • Source: Oncology reports [Oncol Rep] 2024 Jul; Vol. 52 (1). Date of Electronic Publication: 2024 Jun 07.Publisher: D.A. Spandidos Country of Publication: Greece NLM ID: 9422756 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

siRNA treatment targeting integrin α11 overexpressed via EZH2-driven axis inhibits drug-resistant breast cancer progression.

  • Authors : Chaudhary P; College of Pharmacy, Yeungnam University, Gyeongsan, 38541, Republic of Korea.; Yadav K

Subjects: Drug Resistance, Neoplasm*/Drug Resistance, Neoplasm*/Drug Resistance, Neoplasm*/genetics ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/pathology ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/genetics

  • Source: Breast cancer research : BCR [Breast Cancer Res] 2024 Apr 25; Vol. 26 (1), pp. 72. Date of Electronic Publication: 2024 Apr 25.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 100927353 Publication Model: Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Chemoprotective Effect of Daphnetin in Doxorubicin Treated Esophageal Cancer Stem Cell Xenograft Tumor Mouse.

  • Authors : Deng Q; Department of Gartroenterology, The Third Hospital of Mianyang, Sichuan Mental Health Center, 621000, Mianyang, Sichuan, China. .; Wu L

Subjects: Doxorubicin*/Doxorubicin*/Doxorubicin*/pharmacology ; Esophageal Neoplasms*/Esophageal Neoplasms*/Esophageal Neoplasms*/drug therapy ; Esophageal Neoplasms*/Esophageal Neoplasms*/Esophageal Neoplasms*/pathology

  • Source: Doklady. Biochemistry and biophysics [Dokl Biochem Biophys] 2021 Jul; Vol. 499 (1), pp. 273-281. Date of Electronic Publication: 2021 Aug 23.Publisher: Pleiades Publishing Country of Publication: United States NLM ID: 101126895 Publication Model: Print-Electronic

Record details

Read Online Read More Add to Saved list
×
  • 1-10 of  1,506 results for ""Xenograft Model Antitumor Assays""